Showing 6441-6450 of 10618 results for "".
- Key Highlights from Maui Derm Hawaii 2026: Emerging Dermatological Therapeutics and Future Directionshttps://reachmd.com/news/key-highlights-from-maui-derm-hawaii-2026-emerging-dermatological-therapeutics-and-future-directions/2485532/At Maui Derm Hawaii 2026, late-phase data highlighted topical JAK inhibitors (ruxolitinib) a
- Environmental and Clinical Reservoirs of Antimicrobial Resistance: Implications for Genomic Surveillance and Infection Controlhttps://reachmd.com/news/environmental-and-clinical-reservoirs-of-antimicrobial-resistance-implications-for-genomic-surveillance-and-infection-control/2485487/A recent study of environmental Escherichia coli from the Juan Díaz River and Panama City wastewater influent shows high rates of ribosome‑targeting anti
- Midlife Insulin Levels: Implications for Menopausal Symptoms and Cardiometabolic Riskhttps://reachmd.com/news/midlife-insulin-levels-implications-for-menopausal-symptoms-and-cardiometabolic-risk/2485475/University of Victoria researchers report that higher midlife insulin at age 47 predicts an earlier onset and longer duration of menopausal ho
- Transformative AI: Unlocking the Future of Point-of-Care Ultrasoundhttps://reachmd.com/news/transformative-ai-unlocking-the-future-of-point-of-care-ultrasound/2485451/Qure.ai has received a multimillion-dollar grant from the Gates Foundation to support the development of a large, o
- Low-Dose Minocycline Superior in Treating Inflammatory Rosaceahttps://reachmd.com/news/low-dose-minocycline-dfd-29-superior-in-treating-inflammatory-rosacea/2485398/New data presented at 2026 Winter Clinical Hawaii showed DFD-29, a modified low-dose oral minocycline 40 mg, significantly outperformed both placebo and doxycycline 40 mg in the treatment of inflammatory lesions in patients with moderate-to-severe rosacea.
- Enhanced Post-Aortic Repair Surveillance Shows Positive Outcomes: Insights from Michiganhttps://reachmd.com/news/enhanced-post-aortic-repair-surveillance-shows-positive-outcomes-insights-from-michigan/2485371/The Michigan Vascular Partner
- FLAME Trial: Reevaluating Adjunctive Therapy in Trachomatous Trichiasis Surgeryhttps://reachmd.com/news/flame-adjunctive-therapy-trachomatous-trichiasis-surgery/2485314/The FLAME trial found that adjunctive topical fluorometholone did not reduce postoperative trachomatous trichiasis recurrence compared with placebo.
- Lung Immune Prognostic Index: A Tool for Stratifying Survival in Stage III NSCLChttps://reachmd.com/news/lung-immune-prognostic-index-a-tool-for-stratifying-survival-in-stage-iii-nsclc/2485300/Lung Immune Prognostic Index (LIPI) measured at diagnosis stratifies prognosis in stage III non‑small cell lung cancer, identifying a clear gradient of event‑free and over
- Hemoglobin Levels Predict Cyclosporin A Exposure in Pediatric Renal Transplant Patientshttps://reachmd.com/news/hemoglobin-cyclosporin-a-pediatric-renal-transplant/2485289/A population pharmacokinetic analysis of pediatric renal transplant recipients found that hemoglobin strongly influences exposure to cyclosporin A, identifying it as a reproducible covariate that
- Optimizing Perioperative Risk: Understanding the Role of Preoperative Stress in Surgical Outcomeshttps://reachmd.com/news/optimizing-perioperative-risk-understanding-the-role-of-preoperative-stress-in-surgical-outcomes/2485267/Higher preoperative stressor counts predict longer hospital stays, greater postoperative pain, and increased delirium risk in older adults — highlighting the potential value of pragmatic preoperative screening to identify higher-risk patients. In a cohort analysis of